Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

Common cough medicine revealed to slow down Parkinson's disease and dementia - A 12-month study found that Ambroxol helped ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

Researchers at Lawson Research Institute are studying Ambroxol - a common cough medicine in Europe - as a potential treatment for dementia linked to Parkinson’s disease LONDON, Ont. – Dementia ...

A landmark study by London researchers investigating the use of a cough medicine called Ambroxo to slow the progression of ...

Common cough medicine could slow dementia in Parkinson’s patients, study hints Cough medicine widely used in Europe remains unapproved for use in US, Canada, researchers say Vishwam Sankaran ...

An important clinical trial for Parkinson’s disease has just gotten underway in the UK. The placebo-controlled Phase III trial will test whether a long-existing cough medication can slow down ...

"Once the ambroxol trial is underway, it will be one of only six Phase 3 trials on public record of potentially disease-modifying drugs in Parkinson’s, worldwide." Source: UCL Tags ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.